683 Capital Management »

Entrada Therapeutics shares owned by 683 Capital Management

Quarter-by-quarter ownership of Entrada Therapeutics (TRDA) shares owned by 683 Capital Management from 13F filings

Historical chart of 683 Capital Management investment in Entrada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Entrada Therapeutics held by 683 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Entrada Therapeutics by 683 Capital Management

Quarter filed Position value Share count Share price at filing
2023-03-31 $150k 10k 14.50
2022-12-31 $140k 10k 13.52